These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8050611)

  • 41. Structural and membrane-binding properties of saposin D.
    Tatti M; Salvioli R; Ciaffoni F; Pucci P; Andolfo A; Amoresano A; Vaccaro AM
    Eur J Biochem; 1999 Jul; 263(2):486-94. PubMed ID: 10406958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Solution structure and function in trifluoroethanol of PP-50, an ATP-binding peptide from F1ATPase.
    Chuang WJ; Abeygunawardana C; Gittis AG; Pedersen PL; Mildvan AS
    Arch Biochem Biophys; 1995 May; 319(1):110-22. PubMed ID: 7771774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The primary structure of mouse saposin.
    Tsuda M; Sakiyama T; Endo H; Kitagawa T
    Biochem Biophys Res Commun; 1992 May; 184(3):1266-72. PubMed ID: 1590788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of the neurotrophic factor sequence of prosaposin.
    O'Brien JS; Carson GS; Seo HC; Hiraiwa M; Weiler S; Tomich JM; Barranger JA; Kahn M; Azuma N; Kishimoto Y
    FASEB J; 1995 May; 9(8):681-5. PubMed ID: 7768361
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Only sphingolipid activator protein B (SAP-B or saposin B) stimulates the degradation of globotriaosylceramide by recombinant human lysosomal alpha-galactosidase in a detergent-free liposomal system.
    Kase R; Bierfreund U; Klein A; Kolter T; Itoh K; Suzuki M; Hashimoto Y; Sandhoff K; Sakuraba H
    FEBS Lett; 1996 Sep; 393(1):74-6. PubMed ID: 8804427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse.
    Matsuda J; Kido M; Tadano-Aritomi K; Ishizuka I; Tominaga K; Toida K; Takeda E; Suzuki K; Kuroda Y
    Hum Mol Genet; 2004 Nov; 13(21):2709-23. PubMed ID: 15345707
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sequential proton NMR resonance assignments, circular dichroism, and structural properties of a 50-residue substrate-binding peptide from DNA polymerase I.
    Mullen GP; Vaughn JB; Mildvan AS
    Arch Biochem Biophys; 1993 Feb; 301(1):174-83. PubMed ID: 8442659
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mouse testicular sulfated glycoprotein-1: sequence analysis of the common backbone structure of prosaposins.
    Zhao Q; Bell AW; El-Alfy M; Morales CR
    J Androl; 1998; 19(2):165-74. PubMed ID: 9570739
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system.
    Schwarzmann G; Wendeler M; Sandhoff K
    Glycobiology; 2005 Dec; 15(12):1302-11. PubMed ID: 16079415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-Affinity Binding of Monomeric but Not Oligomeric Amyloid-β to Ganglioside GM1 Containing Nanodiscs.
    Thomaier M; Gremer L; Dammers C; Fabig J; Neudecker P; Willbold D
    Biochemistry; 2016 Dec; 55(48):6662-6672. PubMed ID: 27933798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characteristics of asparagine-linked sugar chains of sphingolipid activator protein 1 purified from normal human liver and GM1 gangliosidosis (type 1) liver.
    Yamashita K; Inui K; Totani K; Kochibe N; Furukawa M; Okada S
    Biochemistry; 1990 Mar; 29(12):3030-9. PubMed ID: 2110822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ex vivo localization of the mouse saposin C activation region for acid beta-glucosidase.
    Qi X; Kondoh K; Yin H; Wang M; Ponce E; Sun Y; Grabowski GA
    Mol Genet Metab; 2002 Jul; 76(3):189-200. PubMed ID: 12126932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synopsis: gangliosidoses.
    Schwab ME; Vassella F
    Neuropediatrics; 1984 Sep; 15 Suppl():107-9. PubMed ID: 6100793
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human Saposin B Ligand Binding and Presentation to α-Galactosidase A.
    Sawyer TK; Aral E; Staros JV; Bobst CE; Garman SC
    bioRxiv; 2024 Apr; ():. PubMed ID: 38617236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Saposin A: second cerebrosidase activator protein.
    Morimoto S; Martin BM; Yamamoto Y; Kretz KA; O'Brien JS; Kishimoto Y
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3389-93. PubMed ID: 2717620
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Binding of cerebrosides and sulfatides to saposins A-D.
    Soeda S; Hiraiwa M; O'Brien JS; Kishimoto Y
    J Biol Chem; 1993 Sep; 268(25):18519-23. PubMed ID: 8360153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A hydrophilic peptide comprising 18 amino acid residues of the prosaposin sequence has neurotrophic activity in vitro and in vivo.
    Kotani Y; Matsuda S; Wen TC; Sakanaka M; Tanaka J; Maeda N; Kondoh K; Ueno S; Sano A
    J Neurochem; 1996 May; 66(5):2197-200. PubMed ID: 8780053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Saposin fold revealed by the NMR structure of NK-lysin.
    Liepinsh E; Andersson M; Ruysschaert JM; Otting G
    Nat Struct Biol; 1997 Oct; 4(10):793-5. PubMed ID: 9334742
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activator proteins and topology of lysosomal sphingolipid catabolism.
    Fürst W; Sandhoff K
    Biochim Biophys Acta; 1992 Jun; 1126(1):1-16. PubMed ID: 1606169
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse.
    Matsuda J; Vanier MT; Saito Y; Tohyama J; Suzuki K; Suzuki K
    Hum Mol Genet; 2001 May; 10(11):1191-9. PubMed ID: 11371512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.